Benjamin Deaton, MD
Internal Medicine · Baton Rouge
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- 1
- 1 carrier
- Office
- 1
- Since medical school
- 14 years
- Graduated 2012
Offices
1 location · Our Lady of the Lake Physician Group LLC · 637 clinicians in this group
Hospitals listed: Fmol Health . That is not proof they admit you there this week.
Plans that list them
1 plan · 1 carrier
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Deaton’s office at (225) 765-5864 to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
| Anthem Medicare Advantage (HMO-POS) | Anthem Blue Cross | Listed | Oct 3, 2026 |
California Medical Board record
Licence A147582 · Delinquent
Licence status: Delinquent · since 2017 · expires 2022-12-31 · University of Colorado School of Medicine.
License renewal fee has not been paid. No practice is permitted.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
School, training and certification
What this clinician told their state board, medical school and everything before it. Only some states publish this, so nothing here means the state does not say, not that there was no training or certification.
Specialty certification
- American Board of Internal Medicine - Critical Care Medicine
- American Board of Internal Medicine - Internal Medicine
Hospitals they work in
1 hospital
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- Our Lady of the Lake Regional Medical CenterBaton Rouge, LAAcute Care Hospital · Voluntary non-profit - Church · Has an emergency departmentPart of Franciscan Missionaries of Our Lady Health System, which runs 11 hospitals in 2 statesPatients rate it 3 of 5 · 73% would definitely recommend itOverall rating: 3 of 5 starsBetter than the national rate — Catheter Associated Urinary Tract Infections (ICU + select Wards): 0.38, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.34, Oct 2024 – Sep 2025
See every measure and the patient survey for Our Lady of the Lake Regional Medical Center
Behind the star rating — Deaths: 0 better, 7 the same, 1 worse of 8 measures. Safety: 2 better, 4 the same, 0 worse of 6 measures. Readmissions: 0 better, 10 the same, 0 worse of 10 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.38 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.34 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 0.8 (0 to 1.64) · 1,976 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.85 (0.63 to 1.07) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 201.44 (154.41 to 248.48) · 146 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 2 · 146 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 10.8 · 133 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 13.5 · 168 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 12.4 · 566 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 18.2 · 393 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 14.4 · 1,060 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 5.1 · 8,084 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.22 (0.03 to 0.4) · 9,517 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.19 (0.01 to 0.37) · 9,665 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 4.54 (2.94 to 6.15) · 3,319 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 0.97 (0 to 2.29) · 1,609 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 3.47 (2.33 to 4.6) · 3,130 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 9.27 (5.34 to 13.2) · 1,556 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 4.6 (1.93 to 7.27) · 1,555 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.47 (0.07 to 2.87) · 614 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.18 (0 to 0.67) · 7,739 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 5.9 · 47 cases | None | Apr 2023 – Mar 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.74 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.771 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 0.639 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 15.3 · 436 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 20.4 · 1,805 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | -16.2 · 183 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -4.3 · 667 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | -0.2 · 430 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 17.6 · 977 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 4.3 (3 to 6.2) · 208 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 9.1 (6.9 to 12) · 208 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 7.2 · 43 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 9.9 · 299 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 18.7 · 492 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 12.3 (9.4 to 16.3) · 645 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 1.1 (0.9 to 1.4) · 746 cases | No different | Jan 2024 – Dec 2024 |
What patients said (808 patients answered, 21% of those asked)
| Cleanliness | 3 |
| Nurse communication | 4 |
| Doctor communication | 4 |
| Communication about medicines | 2 |
| Discharge information | 3 |
| Overall hospital rating | 4 |
| Quietness | 4 |
| Recommend hospital | 4 |
| Room was "always" clean | 64% |
| Nurses "always" communicated well | 80% |
| Doctors "always" communicated well | 83% |
| Staff "always" explained | 56% |
| Yes, staff "did" give patients this information | 86% |
| Yes, staff "did" give patients information about help after discharge | 85% |
| Doctors "always" explained things so they could understand | 79% |
| Doctors "always" listened carefully | 81% |
| Doctors "always" treated them with courtesy and respect | 89% |
| Patients who gave a rating of "9" or "10" (high) | 71% |
| Staff "always" explained new medications | 72% |
| Nurses "always" explained things so they could understand | 76% |
| Nurses "always" listened carefully | 76% |
| Nurses "always" treated them with courtesy and respect | 86% |
| "Always" quiet at night | 67% |
| "YES", patients would definitely recommend the hospital | 73% |
| Staff "always" explained possible side effects | 39% |
| Yes, staff "did" give patients information about possible symptoms | 88% |
Original Medicare doctor bills
$16,816
Medicare paid this office $16,816 for 70 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Critical care, first 30-74 minutes | 39 | $11,462 | $157 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 30 | $2,699 | $59 |
Procedures year by year
| Procedure | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|
| Emergent insertion of breathing tube into windpipe using an endoscope | 20 | 12 | 11 | – | – | – |
| Insertion of non-tunneled central venous tube for infusion (5 years or older) | 17 | – | – | – | – | – |
Times billed to Original Medicare each year. A blank year means fewer than 11 people had it, or none: Medicare does not publish smaller counts. Medicare Advantage patients are not included.
Who their Medicare patients are
70 Original Medicare patients in 2024. Average age 72 · Women 47% · Also on Medicaid 34% · Health risk score 2.48. Above the middle of the specialty; the typical internal medicine clinician is at 1.76.
Conditions among them: High blood pressure 75% · Diabetes 53% · Heart failure 53% · Chronic kidney disease 53% · Coronary heart disease 51% · Stroke 51% · Depression 44% · Atrial fibrillation 36% · COPD 34% · Dementia 26% · Cancer 21%.
The office billed $53,828, Medicare allowed $21,411 and paid $16,816; for 148 services of 14 kinds.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 70 | 148 | 72 | 2.48 | $53,828 | $16,816 |
| 2023 | 44 | 94 | 70 | 3.27 | $40,773 | $11,789 |
| 2022 | 88 | 257 | 73 | 3.35 | $134,745 | $36,880 |
| 2021 | 168 | 516 | 73 | 2.41 | $305,180 | $80,927 |
| 2020 | 202 | 561 | 73 | 3.34 | $349,574 | $92,532 |
| 2019 | 221 | 514 | 76 | 2.98 | $522,562 | $77,162 |
| 2018 | 228 | 571 | 73 | 3.58 | $734,234 | $94,591 |
| 2017 | 35 | 76 | 73 | 3.89 | $88,889 | $11,725 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 2 services
| Critical care, first 30-74 minutes | 27 | $7,812 | $163 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 16 | $2,101 | $88 |
2022: 3 services
| Critical care, first 30-74 minutes | 73 | $29,997 | $173 |
| Critical care, each additional 30 minutes | 28 | $3,182 | $88 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 25 | $2,024 | $81 |
2021: 5 services
| Critical care, first 30-74 minutes | 150 | $65,421 | $194 |
| Critical care, each additional 30 minutes | 73 | $8,610 | $98 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 35 | $3,445 | $93 |
| Emergent insertion of breathing tube into windpipe using an endoscope | 11 | $1,357 | $123 |
| Ultrasonic guidance for blood vessel access | 13 | $197 | $12 |
2020: 5 services
| Critical care, first 30-74 minutes | 181 | $77,690 | $198 |
| Critical care, each additional 30 minutes | 51 | $5,926 | $100 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 49 | $5,095 | $94 |
| Emergent insertion of breathing tube into windpipe using an endoscope | 12 | $1,525 | $127 |
| Ultrasonic guidance for blood vessel access | 11 | $183 | $13 |
2019: 5 services
| Critical care, first 30-74 minutes | 150 | $57,801 | $195 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 54 | $7,742 | $93 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 42 | $3,774 | $65 |
| Emergent insertion of breathing tube into windpipe using an endoscope | 20 | $2,461 | $123 |
| Insertion of non-tunneled central venous tube for infusion (5 years or older) | 16 | $1,277 | $75 |
2018: 6 services
| Critical care, first 30-74 minutes | 167 | $74,029 | $196 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 62 | $8,332 | $94 |
| Emergent insertion of breathing tube into windpipe using an endoscope | 24 | $3,067 | $123 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 12 | $2,183 | $182 |
| Critical care, each additional 30 minutes | 12 | $1,372 | $98 |
| Insertion of non-tunneled central venous tube for infusion (5 years or older) | 15 | $1,333 | $89 |
2017: 2 services
| Critical care, first 30-74 minutes | 21 | $7,793 | $195 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 12 | $1,496 | $93 |
Medicaid work
$2,556 in 2024
Medicaid paid $2,556 for 42 billed services this clinician did in 2024, up to 12 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| Critical care, evaluation and management of the critically ill or critically injured patient; first 30-74 minutes | 13 | $1,590 |
| SBSQ HOSPITAL IP/OBS CARE MOD MDM 35 MINUTES | 29 | $966 |
| 2024 | 42 | 2 | 12 | $2,556 |
| 2023 | 31 | 1 | 17 | $3,887 |
| 2022 | 101 | 1 | 14 | $10,447 |
| 2021 | 66 | 1 | 15 | $4,937 |
| 2020 | 80 | 1 | 16 | $7,269 |
| 2019 | 185 | 1 | 19 | $6,028 |
| 2018 | 310 | 2 | 19 | $13,503 |
See the largest Medicaid services in earlier years
2023
| Critical care, evaluation and management of the critically ill or critically injured patient; first 30-74 minutes | 31 | $3,887 |
2022
| Critical care, evaluation and management of the critically ill or critically injured patient; first 30-74 minutes | 101 | $10,447 |
2021
| Critical care, evaluation and management of the critically ill or critically injured patient; first 30-74 minutes | 66 | $4,937 |
2020
| Critical care, evaluation and management of the critically ill or critically injured patient; first 30-74 minutes | 80 | $7,269 |
2019
| Critical care, evaluation and management of the critically ill or critically injured patient; first 30-74 minutes | 185 | $6,028 |
2018
| Critical care, evaluation and management of the critically ill or critically injured patient; first 30-74 minutes | 291 | $13,200 |
| SBSQ HOSPITAL IP/OBS CARE HIGH MDM 50 MINUTES | 19 | $302 |
Drugs they prescribed that Part D paid
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 0% of their 139 Part D prescriptions in 2016.
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
Year by year
| 2016 | 139 | 20 | 0% (0) | None | $3,961 |
| 2015 | 502 | 48 | 8% (38) | None | $47,512 |
| 2014 | 221 | 49 | 5% (11) | None | $13,625 |
| 2013 | 381 | 43 | 10% (37) | 17% | $17,056 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2016: 1 drug
| Amitriptyline | 14 | $354 | $25 |
2015: 13 drugs
| Proair Hfa | 12 | $1,265 | $105 |
| Gabapentin | 47 | $740 | $16 |
| Levothyroxine | 19 | $457 | $24 |
| Pravastatin | 16 | $363 | $23 |
| Amitriptyline | 21 | $342 | $16 |
| Oxycodone | 11 | $270 | $25 |
| Sumatriptan | 16 | $198 | $12 |
| Omeprazole | 18 | $189 | $11 |
| Lisinopril | 20 | $145 | $7 |
| Metformin | 14 | $135 | $10 |
| Furosemide | 11 | $81 | $7 |
| Losartan | 14 | $62 | $4 |
| Hydrochlorothiazide | 13 | $37 | $3 |
2014: 4 drugs
| Gabapentin | 18 | $749 | $42 |
| Metformin | 11 | $131 | $12 |
| Lisinopril | 15 | $117 | $8 |
| Ranitidine | 12 | $95 | $8 |
2013: 11 drugs
| Humalog | 11 | $2,491 | $226 |
| Omeprazole | 20 | $272 | $14 |
| Quinapril | 16 | $268 | $17 |
| Tramadol | 31 | $255 | $8 |
| Oxybutynin Chloride | 14 | $225 | $16 |
| Atorvastatin | 12 | $218 | $18 |
| Hydrochlorothiazide | 30 | $206 | $7 |
| Lactulose | 12 | $175 | $15 |
| Metformin | 17 | $169 | $10 |
| Simvastatin | 14 | $106 | $8 |
| Trazodone | 13 | $67 | $5 |
Money from drug and device companies
$1,060 in 2025
| 2025 | 15 | 42 | None | $1,060 |
| 2024 | 17 | 34 | None | $775 |
| 2023 | 8 | 9 | None | $288 |
| 2022 | 1 | 1 | $137 | $137 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Genzyme | Dupixent | $307 | 8 payments
|
| Abiomed | None | $190 | 5 payments
|
| AstraZeneca Pharmaceuticals LP | Breztri | $103 | 5 payments
|
| Grifols USA | Prolastin-C Liquid | $88 | 3 payments
|
| Baxter Healthcare | Hillrom - Vest System Model 105 Home Care | $59 | 3 payments
|
| Viatris Specialty | Yupelri | $50 | 2 payments
|
See all 42 published payments
| Medtronic | Meals · 2025-12-02 | Vitalflow Console | $31 |
| Genzyme | Meals · 2025-11-24 | Dupixent | $32 |
| Abiomed | Meals · 2025-11-20 | None | $13 |
| Abiomed | Meals · 2025-11-20 | None | $3 |
| Liquidia Technologies | Meals · 2025-11-19 | Yutrepia | $18 |
| Merck Sharp & Dohme | Meals · 2025-11-12 | Zerbaxa | $19 |
| Pfizer | Meals · 2025-10-23 | Eliquis | $18 |
| AstraZeneca Pharmaceuticals LP | Meals · 2025-10-07 | Tezspire | $21 |
| Verona Pharma | Meals · 2025-10-01 | Ohtuvayre | $20 |
| Grifols USA | Meals · 2025-10-01 | Prolastin-C Liquid | $31 |
| ANI Pharmaceuticals | Meals · 2025-09-29 | Purified Cortrophin Gel | $30 |
| Abiomed | Meals · 2025-09-16 | None | $45 |
| Electromed | Meals · 2025-09-16 | Smartvest | $2 |
| Electromed | Meals · 2025-09-16 | Smartvest | $0 |
| Abiomed | Meals · 2025-09-15 | None | $15 |
| Genzyme | Meals · 2025-09-15 | Dupixent | $40 |
| Merck Sharp & Dohme | Meals · 2025-09-12 | Zerbaxa | $18 |
| Electromed | Meals · 2025-08-29 | Smartvest | $11 |
| Genzyme | Meals · 2025-08-26 | Dupixent | $40 |
| AstraZeneca Pharmaceuticals LP | Meals · 2025-08-22 | Breztri | $23 |
| Baxter Healthcare | Meals · 2025-08-07 | Hillrom - Vest System Model 105 Home Care | $21 |
| AstraZeneca Pharmaceuticals LP | Meals · 2025-08-06 | Tezspire | $19 |
| Genzyme | Meals · 2025-07-22 | Dupixent | $40 |
| Grifols USA | Meals · 2025-07-09 | Prolastin-C Liquid | $27 |
| AstraZeneca Pharmaceuticals LP | Meals · 2025-07-08 | Breztri | $20 |
| Baxter Healthcare | Meals · 2025-07-01 | Hillrom - Vest System Model 105 Home Care | $22 |
| Verona Pharma | Meals · 2025-06-30 | Ohtuvayre | $22 |
| Actelion Pharmaceuticals US | Meals · 2025-06-19 | Uptravi | $22 |
| Viatris Specialty | Meals · 2025-06-13 | Yupelri | $21 |
| Genzyme | Meals · 2025-06-03 | Dupixent | $39 |
| Electromed | Meals · 2025-05-30 | Smartvest | $13 |
| Electromed | Meals · 2025-04-15 | Smartvest | $7 |
| Genzyme | Meals · 2025-04-14 | Dupixent | $39 |
| Grifols USA | Meals · 2025-04-13 | Prolastin-C Liquid | $29 |
| AstraZeneca Pharmaceuticals LP | Meals · 2025-03-19 | Breztri | $21 |
| Electromed | Meals · 2025-03-05 | Smartvest | $11 |
| Viatris Specialty | Meals · 2025-03-05 | Yupelri | $28 |
| Genzyme | Meals · 2025-02-24 | Dupixent | $40 |
| Abiomed | Meals · 2025-02-18 | None | $115 |
| Baxter Healthcare | Meals · 2025-01-31 | Hillrom - Vest System Model 105 Home Care | $16 |
| CoapTech | Meals · 2025-01-30 | Puma System | $22 |
| Genzyme | Meals · 2025-01-02 | Dupixent | $38 |
See earlier years (2024, 2023, 2022)
2024: $775
| Genzyme | Dupixent | $176 | 6 payments
|
| Janssen Pharmaceuticals | Xarelto | $74 | 3 payments
|
| Grifols USA | Prolastin-C Liquid | $69 | 3 payments
|
| AstraZeneca Pharmaceuticals LP | Fasenra | $56 | 3 payments
|
| Merck Sharp & Dohme | Zerbaxa | $45 | 2 payments
|
| CoapTech | Puma System | $44 | 1 payment
|
| Ucb | Briviact | $41 | 2 payments
|
| Abiomed | Impella | $38 | 1 payment
|
| Boehringer Ingelheim Pharmaceuticals | Ofev | $37 | 2 payments
|
| Shionogi | Fetroja | $37 | 2 payments
|
| Vifor Pharma | Veltassa | $27 | 1 payment
|
| Insmed | Arikayce | $23 | 1 payment
|
| La Jolla Pharmaceutical | Giapreza | $22 | 1 payment
|
| Electromed | Smartvest | $22 | 3 payments
|
| Mylan Specialty L.P. | Yupelri | $22 | 1 payment
|
| Baxter Healthcare | Hillrom - Vest System Model 105 Home Care | $22 | 1 payment
|
| United Therapeutics | Tyvaso | $21 | 1 payment
|
2023: $288
| Abiomed | Impella | $98 | 1 payment
|
| Actelion Pharmaceuticals US | Uptravi | $54 | 2 payments
|
| Regeneron Healthcare Solutions | Dupixent | $27 | 1 payment
|
| Baxter Healthcare | Hillrom - Life 2000 Ventilation System | $25 | 1 payment
|
| Grifols USA | Prolastin-C Liquid | $24 | 1 payment
|
| United Therapeutics | Tyvaso | $22 | 1 payment
|
| GlaxoSmithKline | Trelegy Ellipta | $20 | 1 payment
|
| Boehringer Ingelheim Pharmaceuticals | Ofev | $17 | 1 payment
|
2022: $137
| Nuwellis | Aquadex Smartflow Console | $137 | 1 payment
|
Professional record
- NPI
- 1376803437
- Licence
- CA A147582, LA 324895, NM MD2015-0617, NM RS2012-0502California A147582: Delinquent · expires 2022-12-31
- Gender
- Male
More record details
- Sole proprietor
- No
- Taxonomy
- Federal specialty code 207RC0200X (207RC0200X); Internal medicine (207R00000X); Student in a training program (390200000X)
- Mailing address
- 5959 S Sherwood Forest Blvd, Baton Rouge, LA, 70816
- NPI first listed
- 2012-05-23
- NPI last updated
- 2023-07-31
- NPI record certified
- 2023-07-31
This is when the NPI record was last certified, not a medical board exam.
Extra NPI addresses: 17000 Medical Center Dr, Baton Rouge, LA, 70816 · 2000 Mowry Ave, Fremont, CA, 94538 · 225 N Jackson Ave, San Jose, CA, 95116